...
search icon
bvs-img

Bioventus Inc, Common Stock

BVS

NSQ

$10.01

+$0.06

(0.6%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$650.41M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
418.70K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.84
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.9 L
$14.38 H
$10.01

About Bioventus Inc, Common Stock

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameBVSSectorS&P500
1-Week Return-3.84%1.67%0.11%
1-Month Return-2.15%3.31%1.23%
3-Month Return-13.03%2.21%2.87%
6-Month Return9.76%-4.82%8.93%
1-Year Return128.02%1.22%22.83%
3-Year Return-14.08%15.75%42.13%
5-Year Return-47.89%42.34%83.14%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue340.14M321.16M430.90M512.12M512.35M[{"date":"2019-12-31","value":66.39,"profit":true},{"date":"2020-12-31","value":62.68,"profit":true},{"date":"2021-12-31","value":84.1,"profit":true},{"date":"2022-12-31","value":99.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue90.94M87.64M128.19M181.04M184.15M[{"date":"2019-12-31","value":49.38,"profit":true},{"date":"2020-12-31","value":47.59,"profit":true},{"date":"2021-12-31","value":69.61,"profit":true},{"date":"2022-12-31","value":98.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit249.21M233.52M302.71M331.08M328.19M[{"date":"2019-12-31","value":75.27,"profit":true},{"date":"2020-12-31","value":70.53,"profit":true},{"date":"2021-12-31","value":91.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.13,"profit":true}]
Gross Margin73.27%72.71%70.25%64.65%64.06%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.24,"profit":true},{"date":"2021-12-31","value":95.88,"profit":true},{"date":"2022-12-31","value":88.24,"profit":true},{"date":"2023-12-31","value":87.43,"profit":true}]
Operating Expenses217.44M211.72M281.65M379.70M409.92M[{"date":"2019-12-31","value":53.04,"profit":true},{"date":"2020-12-31","value":51.65,"profit":true},{"date":"2021-12-31","value":68.71,"profit":true},{"date":"2022-12-31","value":92.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income31.19M21.24M17.72M(35.68M)(81.72M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.08,"profit":true},{"date":"2021-12-31","value":56.81,"profit":true},{"date":"2022-12-31","value":-114.37,"profit":false},{"date":"2023-12-31","value":-262,"profit":false}]
Total Non-Operating Income/Expense(43.08M)(15.07M)(3.69M)(47.59M)(90.94M)[{"date":"2019-12-31","value":-4308300000,"profit":false},{"date":"2020-12-31","value":-1507400000,"profit":false},{"date":"2021-12-31","value":-368500000,"profit":false},{"date":"2022-12-31","value":-4758600000,"profit":false},{"date":"2023-12-31","value":-9094500000,"profit":false}]
Pre-Tax Income9.69M15.91M7.62M(263.90M)(121.11M)[{"date":"2019-12-31","value":60.88,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":47.88,"profit":true},{"date":"2022-12-31","value":-1658.28,"profit":false},{"date":"2023-12-31","value":-761.03,"profit":false}]
Income Taxes1.58M1.19M(1.97M)(50.51M)85.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":75.63,"profit":true},{"date":"2021-12-31","value":-124.75,"profit":false},{"date":"2022-12-31","value":-3204.82,"profit":false},{"date":"2023-12-31","value":5.39,"profit":true}]
Income After Taxes8.11M14.72M9.59M(213.39M)(121.20M)[{"date":"2019-12-31","value":55.11,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":65.11,"profit":true},{"date":"2022-12-31","value":-1449.47,"profit":false},{"date":"2023-12-31","value":-823.23,"profit":false}]
Income From Continuous Operations8.11M14.72M9.59M(213.39M)(203.76M)[{"date":"2019-12-31","value":55.11,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":65.11,"profit":true},{"date":"2022-12-31","value":-1449.47,"profit":false},{"date":"2023-12-31","value":-1384.03,"profit":false}]
Income From Discontinued Operations(1.81M)----[{"date":"2019-12-31","value":-181500000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income6.85M16.41M9.59M(213.39M)(156.23M)[{"date":"2019-12-31","value":41.75,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":58.41,"profit":true},{"date":"2022-12-31","value":-1300.29,"profit":false},{"date":"2023-12-31","value":-951.98,"profit":false}]
EPS (Diluted)-2.340.820.16-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.04,"profit":true},{"date":"2022-12-31","value":6.84,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BVS
Cash Ratio 0.20
Current Ratio 1.41
Quick Ratio 0.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BVS
ROA (LTM) 2.48%
ROE (LTM) -24.76%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BVS
Debt Ratio Lower is generally better. Negative is bad. 0.76
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.19

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BVS
Trailing PE NM
Forward PE 17.48
P/S (TTM) 1.17
P/B 4.54
Price/FCF 63
EV/R 1.83
EV/Ebitda 31.80
PEG 2.14

FAQs

What is Bioventus Inc share price today?

Bioventus Inc (BVS) share price today is $10.01

Can Indians buy Bioventus Inc shares?

Yes, Indians can buy shares of Bioventus Inc (BVS) on Vested. To buy Bioventus Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BVS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bioventus Inc be purchased?

Yes, you can purchase fractional shares of Bioventus Inc (BVS) via the Vested app. You can start investing in Bioventus Inc (BVS) with a minimum investment of $1.

How to invest in Bioventus Inc shares from India?

You can invest in shares of Bioventus Inc (BVS) via Vested in three simple steps:

  • Click on Sign Up or Invest in BVS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bioventus Inc shares
What is Bioventus Inc 52-week high and low stock price?

The 52-week high price of Bioventus Inc (BVS) is $14.38. The 52-week low price of Bioventus Inc (BVS) is $3.9.

What is Bioventus Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bioventus Inc (BVS) is 4.54

What is the Market Cap of Bioventus Inc?

The market capitalization of Bioventus Inc (BVS) is $650.41M

What is Bioventus Inc’s stock symbol?

The stock symbol (or ticker) of Bioventus Inc is BVS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top